Shaoxian Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shaoxian Liang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Hongjuan Cao
Department of Chronic Non-communicable Diseases Prevention and Control, Lu’an Municipal Center for Disease Control and Prevention, Lu’an, China (H.C.).
2 shared publications - Wanshui Yang
Department of Nutrition, Center for Big Data and Population Health of IHM, School of Public Health, Anhui Medical University, Hefei, China
2 shared publications - Zhuang Zhang
Department of Nutrition, Center for Big Data and Population Health of IHM, School of Public Health, Anhui Medical University, China
2 shared publications - Danni Wang
Department of Health Promotion and Behavioral Sciences, School of Public Health, Anhui Medical University
1 shared publication - Honghua Zhang
Department of Nutrition, Center for Big Data and Population Health of IHM School of Public Health, Anhui Medical University Hefei Anhui China
1 shared publication - Qihong Zhao
Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, China
1 shared publication
Latest Publications
- Open Access
- 21 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (20) , e043797
Physical Activity, Gut Microbiota, and the Risk of Dyslipidemia in a Community‐Based Cohort Study
Background: Whether moderate‐to‐vigorous physical activity (MVPA) mitigates the detrimental association between sedentary behavior and dyslipidemia remains unclear, as does the link between MVPA and gut microbiota. Methods: We prospectively evaluated the joint association between MVPA and sedentary time on dyslipidemia risk in a cohort of 2942 Chinese adults, where PA was measured by a validated self‐reported questionnaire. In a subcohort ( n =754), 1‐year gut microbial changes associated with MVPA were assessed via fecal samples collected twice at 1‐year intervals for 16S ribosomal RNA sequencing, with PA intensively assessed by 4 quarterly 3‐day PA diaries (2 weekdays and 1 weekend day) during the year. Results: From 2020 to 2025, 306 dyslipidemia were newly diagnosed. Prolonged sedentary hours increased dyslipidemia risk by 63% (highest versus lowest tertile: adjusted hazard ratio [HR], 1.63 [95% CI, 1.19–2.22], P trend =0.002). Compared with participants with long sedentary hours and low MVPA levels (ie, long‐low group), HRs of dyslipidemia for those in short‐high, short‐low, and long‐high groups were 0.70 (95% CI, 0.50–0.98), 0.99 (95% CI, 0.71–1.37), and 0.83 (95% CI, 0.60–1.16), respectively. The microbial α‐diversity declined in the low MVPA group ( P =0.024), and β‐diversity shifted in both low/high MVPA groups (all P ≤0.005). We identified 7 MVPA‐associated and 13 sedentary time‐associated genera (all P FALSE DISCOVERY RATE Eggerthella and Desulfovibrio correlated positively with MVPA levels but inversely with sedentary time, and Desulfovibrio was inversely associated with dyslipidemia (odds ratio, 0.78 [95% CI, 0.606–0.997]). Conclusions: MVPA attenuates the positive association between sedentary time and dyslipidemia risk and modulates gut microbial diversity and richness, suggesting microbiota‐mediated pathways for dyslipidemia prevention.
- 21 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (20) , e043797
Open AccessPhysical Activity, Gut Microbiota, and the Risk of Dyslipidemia in a Community‐Based Cohort Study
Background: Whether moderate‐to‐vigorous physical activity (MVPA) mitigates the detrimental association between sedentary behavior and dyslipidemia remains unclear, as does the link between MVPA and gut microbiota. Methods: We prospectively evaluated the joint association between MVPA and sedentary time on dyslipidemia risk in a cohort of 2942 Chinese adults, where PA was measured by a validated self‐reported questionnaire. In a subcohort ( n =754), 1‐year gut microbial changes associated with MVPA were assessed via fecal samples collected twice at 1‐year intervals for 16S ribosomal RNA sequencing, with PA intensively assessed by 4 quarterly 3‐day PA diaries (2 weekdays and 1 weekend day) during the year. Results: From 2020 to 2025, 306 dyslipidemia were newly diagnosed. Prolonged sedentary hours increased dyslipidemia risk by 63% (highest versus lowest tertile: adjusted hazard ratio [HR], 1.63 [95% CI, 1.19–2.22], P trend =0.002). Compared with participants with long sedentary hours and low MVPA levels (ie, long‐low group), HRs of dyslipidemia for those in short‐high, short‐low, and long‐high groups were 0.70 (95% CI, 0.50–0.98), 0.99 (95% CI, 0.71–1.37), and 0.83 (95% CI, 0.60–1.16), respectively. The microbial α‐diversity declined in the low MVPA group ( P =0.024), and β‐diversity shifted in both low/high MVPA groups (all P ≤0.005). We identified 7 MVPA‐associated and 13 sedentary time‐associated genera (all P FALSE DISCOVERY RATE Eggerthella and Desulfovibrio correlated positively with MVPA levels but inversely with sedentary time, and Desulfovibrio was inversely associated with dyslipidemia (odds ratio, 0.78 [95% CI, 0.606–0.997]). Conclusions: MVPA attenuates the positive association between sedentary time and dyslipidemia risk and modulates gut microbial diversity and richness, suggesting microbiota‐mediated pathways for dyslipidemia prevention.
- Open Access
- 2 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e034126
Urinary Equol and Equol‐Predicting Microbial Species Are Favorably Associated With Cardiometabolic Risk Markers in Chinese Adults
Background: The association between soy isoflavones intake and cardiometabolic health remains inconclusive. We investigated the associations of urinary biomarkers of isoflavones including daidzein, glycitein, genistein, equol (a gut microbial metabolite of daidzein), and equol‐predicting microbial species with cardiometabolic risk markers. Methods and Results: In a 1‐year study of 305 Chinese community‐dwelling adults aged ≥18 years, urinary isoflavones, fecal microbiota, blood pressure, blood glucose and lipids, and anthropometric data were measured twice, 1 year apart. Brachial‐ankle pulse wave velocity was also measured after 1 year. A linear mixed‐effects model was used to analyze repeated measurements. Logistic regression was used to calculate the adjusted odds ratio (aOR) and 95% CI for the associations for arterial stiffness. Each 1 μg/g creatinine increase in urinary equol concentrations was associated with 1.47%, 0.96%, and 3.32% decrease in triglycerides, plasma atherogenic index, and metabolic syndrome score, respectively (all P P =0.025). Urinary equol was also associated with lower risk of arterial stiffness (aOR, 0.28 [95% CI, 0.09–0.90]; P trend =0.036). We identified 21 bacterial genera whose relative abundance was positively associated with urinary equol (false discovery rate‐corrected P P <0.05). Conclusions: Our findings suggest that urinary equol and equol‐predicting microbial species may improve cardiometabolic risk parameters in Chinese adults.
- 2 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e034126
Open AccessUrinary Equol and Equol‐Predicting Microbial Species Are Favorably Associated With Cardiometabolic Risk Markers in Chinese Adults
Background: The association between soy isoflavones intake and cardiometabolic health remains inconclusive. We investigated the associations of urinary biomarkers of isoflavones including daidzein, glycitein, genistein, equol (a gut microbial metabolite of daidzein), and equol‐predicting microbial species with cardiometabolic risk markers. Methods and Results: In a 1‐year study of 305 Chinese community‐dwelling adults aged ≥18 years, urinary isoflavones, fecal microbiota, blood pressure, blood glucose and lipids, and anthropometric data were measured twice, 1 year apart. Brachial‐ankle pulse wave velocity was also measured after 1 year. A linear mixed‐effects model was used to analyze repeated measurements. Logistic regression was used to calculate the adjusted odds ratio (aOR) and 95% CI for the associations for arterial stiffness. Each 1 μg/g creatinine increase in urinary equol concentrations was associated with 1.47%, 0.96%, and 3.32% decrease in triglycerides, plasma atherogenic index, and metabolic syndrome score, respectively (all P P =0.025). Urinary equol was also associated with lower risk of arterial stiffness (aOR, 0.28 [95% CI, 0.09–0.90]; P trend =0.036). We identified 21 bacterial genera whose relative abundance was positively associated with urinary equol (false discovery rate‐corrected P P <0.05). Conclusions: Our findings suggest that urinary equol and equol‐predicting microbial species may improve cardiometabolic risk parameters in Chinese adults.